Here are relevant reports on : skin-care-device-market
-
Europe Wound Care Market by Product [Dressings (Foam, Hydrocolloid, Collagen), Devices (NPWT, Debridement), Biological Skin Substitutes, Sutures, Staplers], Wound [Chronic, Acute], End User [Hospitals, Clinics, Home Care] -Forecast to 2031
The Europe Wound Care Market, valued at USD 6.62 billion in 2025, stood at USD 6.98 billion in 2026 and is projected to advance at a resilient CAGR of 6.0% from 2026 to 2031, culminating in a forecasted valuation of USD 9.33 billion by the end of the period. Growth momentum across Europe is fueled by the integration of advanced wound care technologies into European healthcare infrastructure, an emphasis on early diagnosis, and the development of wound care products for chronic and acute wounds.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Cosmeceuticals Market by Product (Skin Care (Whitening, Exfoliators), Hair Care), Material (Natural, Synthetic), Active Ingredient (Antioxidants, Retinoid, Botanicals), Distribution Channel (Pharmacy, Online Store) - Global Forecasts to 2023
Cosmeceuticals are products that have both cosmetic and medicinal properties (medical or drug-like) effects, and are intended to have a beneficial effect on the skin health and beauty. These products are similar to the cosmetics; they are applied topically as creams or lotions but contain an active ingredient that has an effect on skin cell functions. Some of the cosmeceutical product’s action is limited to skin care (such as exfoliants) while others can penetrate to deeper levels, either enhancing or limiting the normal skin functions. Cosmeceutical products are available as over-the-counter and are generally used as a part of the regular skin care treatment to help improvise skin tone, and texture, pigmentation, and fine lines. Antioxidants, retinoid, exfoliants, peptides and proteins, and botanical extracts are some of the common ingredients used in cosmeceutical products. Cosmeceutical active ingredients are constantly being developed by various emerging as well as international players that are engaged in pharmaceutical, biotechnology, cosmetics, and natural products, on the other hand, advancements in the field of dermatology and pharmacology have accelerated the development of novel active compound (such as liposomes) more rapidly.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Cosmetic Antioxidants Market by Source (Natural, Synthetic), Type (Vitamins, Enzymes, Polyphenols), Function (Anti-aging, Hair Conditioning, UV Protection), and Application (Skin Care, Hair Care, Make-up)- Global Forecast to 2028
The Cosmetic Antioxidants Market is expected to grow from USD 119 million in 2020 to USD 158 million by 2025, at a CAGR of 5.9% during the forecast period. The key market players profiled in the report include as BASF SE (Germany), Koninklijke DSM N.V. (Netherlands), Wacker Chemie AG (Germany), Eastman Chemical Company (US), Lonza Group (Switzerland), Croda International Plc (UK), Ashland Global Holdings (US), Evonik Industries AG (Germany), SEPPIC (France), BTSA Biotecnologías Aplicadas, S.L. (Spain), Kemin Industries, Inc. (US), and Barentz International BV (Netherlands) among others.
- Published: August 2023
- Price: $ 4950
- TOC Available:
-
US Wound Care Market by Product [Dressings (Foam, Hydrocolloid, Collagen), Devices (NPWT, Debridement), Biological Skin Substitutes, Sutures, Staplers], Wound [Chronic, Acute], End User [Hospitals, Clinics, Home Care]-Forecast to 2031
The US wound care market, valued at USD 6.63 billion in 2025, stood at USD 7.01 billion in 2026 and is projected to advance at a resilient CAGR of 6.1% from 2026 to 2031, culminating in a forecasted valuation of USD 9.44 billion by the end of the period. The growth of US wound care products is primarily driven by trauma and burn injuries, the rising prevalence of chronic diseases, and the growing geriatric population.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Medical Device Outsourced Manufacturing Market by Device Type (IVD (Equipment, Consumable), Diabetes, Respiratory, Cardiovascular, Personal Care, Endoscopy, Dental, Ophthalmology, Devices) Class of Device, Services, Procedure - Forecast to 2026
The global medical device outsourced manufacturing market growth is primed to transition from $29.3 billion in 2021 to $56.2 billion by 2026, showcasing a strong CAGR of 13.9%. The medical device outsourced manufacturing market is mainly driven by the overall growth of the medical devices market, mainly due to the rising disease prevalence, life expectancy, and geriatric population. Technological advancements have prompted end users to overhaul or update their manufacturing systems.
- Published: April 2021
- Price: $ 4950
- TOC Available:
-
Incontinence and Ostomy Care Market by Procedure (Ileostomy, Urostomy, Colostomy), Disease (Cancer, Crohn's Disease, Diarrhea), Product (Adsorbent, Deodorizer, Ostomy Bag, Skin Barrier), Application (Protection, Cleansing) Global Forecasts to 2019
The global incontinence and ostomy care market is estimated to grow at a high rate from 2014 to 2019. The key drivers propelling the growth of global incontinence and ostomy care market include global rise in population of obese and geriatric individuals, development of innovative and personalized products offering greater patient comfort, rising awareness and acceptance related to ostomy care products, and increasing prevalence of target diseases.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
North America Respiratory Care Device Market by Product (PAP Device, Ventilator, Humidifier, Oxygen Concentrator, Spirometer, Peak Flow Meter, Mask), Disease Indication (Asthma, Infectious Disease), End User (Hospital, Homecare Setting)-Forecast to 2031
The North America Respiratory Care Device market, valued at US$9.88 billion in 2025, stood at US$10.53 billion in 2026 and is projected to advance at a resilient CAGR of 7.8% from 2026 to 2031, culminating in a forecasted valuation of US$15.31 billion by the end of the period. The North America respiratory care devices market has been growing as the number of chronic respiratory diseases, such as COPD, asthma, and sleep apnea, continues to rise.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
US Respiratory Care Device Market by Product (PAP Devices, Ventilators, Humidifiers, Oxygen Concentrators, Spirometers, Peak Flow Meter, Masks), Disease Indication (Asthma, Infectious Disease), End User (Hospitals, Home Care Settings) - Forecast to 2031
The US Respiratory Care Devices market, valued at US$9.40 billion in 2025, stood at US$10.02 billion in 2026 and is projected to advance at a resilient CAGR of 7.8% from 2026 to 2031, culminating in a forecasted valuation of US$14.56 billion by the end of the period. This growth is primarily driven by an increasing prevalence of chronic respiratory diseases such as COPD, asthma, and sleep apnea, along with an aging population that is more susceptible to breathing disorders.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Dermatology Devices Market Size, Growth by Type (Diagnostic Devices (Dermatoscopes, Imaging Devices), Treatment Devices (Laser, Cryotherapy, Liposuction)), Application (Skin Cancer, Acne, Psoriasis, Skin Rejuvenation, Tattoo Removal) & Region - Global Forecast to 2027
The global dermatology devices market in terms of revenue was estimated to be worth $6.2 billion in 2022 and is poised to reach $11.3 billion by 2027, growing at a CAGR of 12.7% from 2022 to 2027. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: June 2022
- Price: $ 4950
- TOC Available:
-
Skin Health Foods Market by Indication (Skin Conditions, Anti-Aging, Anti-Allergy), Region (North America, Europe, Asia Pacific, Rest of the World), Regulatory Landscape, Pricing Analysis - Global Forecast to 2026
The global skin health foods market growth is primed to transition from $1,929.5 million in 2021 to $2,651.5 million by 2026, showcasing a strong CAGR of 6.6%. The growth of this market is mainly driven by the high incidence of allergic diseases, the growth in health awareness among consumers, increasing R&D and production capacity for functional food and beverage products, and the increasing consumption of nutrient-enriched foods to improve overall health.
- Published: July 2022
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
